Pathogenic fungi have emerged as significant causes of infectious morbidity and death in
patients with acquired immunodeficiency conditions such as HIV/AIDS and following receipt …

Fungal endocarditis accounts for 1% to 3% of all infective endocarditis cases, is associated
with high morbidity and mortality (> 70%), and presents numerous challenges during clinical …

Aspergillus species are the most frequent cause of fungal infections of the lungs with a
broad spectrum of clinical presentations including invasive pulmonary aspergillosis (IPA) …

Abstract Purpose of Review For this review, we use a One Health approach to examine two
globally emerging public health threats related to antifungal drug resistance: triazole …

Potential airborne human pathogens (PAHPs) may be a relevant component of the air
microbiome in built environments. Despite that PAHPs can cause infections, particularly in …

Molds are ubiquitous in the environment, and immunocompromised patients are at
substantial risk of morbidity and mortality due to their underlying disease and the resistance …

Fungal infections are a serious global concern because of their ability to spread and
colonize host tissues in immunocompromised individuals. Such infections have been …

Secondary fungal infections may complicate the clinical course of patients affected by viral
respiratory diseases, especially those admitted to intensive care unit. Hospitalized COVID …

The understanding of therapeutic properties is important in drug repositioning and drug
discovery. However, chemical or clinical trials are expensive and inefficient to characterize …

Fungal infections remain a significant concern for human health. The emergence of
microbial resistance, the improper use of antimicrobial drugs, and the need for fewer toxic …